AA
VYGR icon

ALPS Advisors’s Voyager Therapeutics VYGR Stock Holding History

ALPS Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-38,149
Closed -$302K – 1142
2024
Q2 		$302K Sell
38,149
-204
-0.5% -$1.71K ﹤0.01% 842
2024
Q1 		$357K Buy
38,353
+2,917
+8% +$24.6K ﹤0.01% 790
2023
Q4 		$299K Sell
35,436
-2,464
-7% -$17.9K ﹤0.01% 854
2023
Q3 		$294K Buy
+37,900
New +$346K ﹤0.01% 888
2021
Q2 		– Sell
-67,782
Closed -$319K – 920
2021
Q1 		$319K Buy
67,782
+761
+1% +$5.19K ﹤0.01% 783
2020
Q4 		$479K Buy
67,021
+19,291
+40% +$185K 0.01% 504
2020
Q3 		$509K Sell
47,730
-2,966
-6% -$34.8K 0.01% 436
2020
Q2 		$640K Sell
50,696
-16,701
-25% -$194K 0.01% 414
2020
Q1 		$617K Sell
67,397
-7,863
-10% -$90.2K 0.01% 408
2019
Q4 		$1.05M Buy
75,260
+1,576
+2% +$22.9K 0.01% 339
2019
Q3 		$1.27M Sell
73,684
-3,408
-4% -$71.5K 0.01% 267
2019
Q2 		$2.1M Sell
77,092
-1,545
-2% -$35.4K 0.02% 219
2019
Q1 		$1.5M Buy
78,637
+3,394
+5% +$44.2K 0.01% 261
2018
Q4 		$707K Buy
75,243
+17,844
+31% +$229K 0.01% 390
2018
Q3 		$1.09M Buy
57,399
+10,499
+22% +$201K 0.01% 369
2018
Q2 		$916K Buy
+46,900
New +$927K 0.01% 353

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ALPS Advisors's VYGR Position: Q3 2024 in Review

ALPS Advisors sold out of Voyager Therapeutics (VYGR) in Q3 2024, closing a stake of 38,149 shares — an estimated $302K sold.

ALPS Advisors first reported a position in VYGR in Q2 2018 and held it in 16 quarters. The position peaked at $2.1M in Q2 2019. 128 funds tracked by Wall St. Rank hold VYGR as of Q3 2024.

  • ALPS Advisors reported no remaining Voyager Therapeutics position as of Q3 2024 after selling out during the quarter.
  • ALPS Advisors sold 38,149 Voyager Therapeutics shares in Q3 2024, an estimated $302K.
  • ALPS Advisors first reported a position in Voyager Therapeutics in Q2 2018 and held it in 16 quarters.
  • ALPS Advisors's Voyager Therapeutics position peaked at $2.1M in Q2 2019.
  • 128 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2024.

Based on ALPS Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.